fda bpc-157 unapproved new drug warning not approved The FDA has issued clear signals on fda warning bpc-157 peptide unapproved

It is generally recommended for individuals who: Have a body mass index (BMI) of 30 or higher (obesity), or a BMI of 27 or higher with at least one weight-related health condition (such as high blood pressure, type 2 diabetes, or high cholesterol)

In the CY 2026 OPPS/ASC proposed rule, we noted that the proposed data collection requirement would apply to a smaller subset of hospitals as compared to the public reporting requirements under the hospital price transparency regulations

Starting with the IV after my half marathon all the way to Botox and filler

Risk factors for surgical site infection in advanced neuromodulation pain procedures: A retrospective study